Literature DB >> 24299308

Loss of MTUS1 in gastric cancer promotes tumor growth and metastasis.

X Li, H Liu, T Yu, Z Dong, L Tang, X Sun.   

Abstract

Though the overall incidence of gastric cancer was decreasing in the developed countries in the past decades, it is still a serious threat to human health throughout the world. The molecular mechanisms underlying development of gastric cancer remains unclear. Though accumulating evidences shed a light on the implications of mitochondrial tumor suppressor (MTUS1) in carcinogenesis, the functional role of MTUS1 in regulation of proliferation and metastasis of gastric cancer cell is still poorly understood. In this study, we showed that the level of MTUS1 expression is relatively low in gastric cancer cell lines compared to normal gastric epithelial cells. By using clinical samples, we found that MTUS1 expression is downregulated in tumor tissues compared to non-cancerous counterpart, and loss of MTUS1 was associated with high incidence of lymph node metastasis and poor patient outcome. Moreover, we demonstrate that MTUS1 has a significant impact on both the proliferative and metastatic potential of gastric cancer cell line, which were further supported by using mice tumor xenograft models. The present data suggested MTUS1 as a potential tumor suppressor in gastric cancer and might lead to a better understanding of gastric carcinogenesis.

Entities:  

Keywords:  gastric cancer, MTUS1, proliferation, metastasis

Mesh:

Substances:

Year:  2014        PMID: 24299308     DOI: 10.4149/neo_2014_018

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  11 in total

1.  Loss of MTUS1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Carcinoma.

Authors:  Jongmin Sim; Yeseul Kim; Hyungsung Kim; Seongsik Bang; Seungyun Jee; Seongun Park; Su-Jin Shin; Kiseok Jang
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

2.  Genomic alterations on 8p21-p23 are the most frequent genetic events in stage I squamous cell carcinoma of the lung.

Authors:  Jiun Kang
Journal:  Exp Ther Med       Date:  2014-12-09       Impact factor: 2.447

3.  MTUS1/ATIP3a down-regulation is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma.

Authors:  Tingting Zhao; Xueqiang Ding; Boyang Chang; Xiaofeng Zhou; Anxun Wang
Journal:  BMC Cancer       Date:  2015-03-31       Impact factor: 4.430

4.  Identification of expression patterns in the progression of disease stages by integration of transcriptomic data.

Authors:  Sara Aibar; Maria Abaigar; Francisco Jose Campos-Laborie; Jose Manuel Sánchez-Santos; Jesus M Hernandez-Rivas; Javier De Las Rivas
Journal:  BMC Bioinformatics       Date:  2016-11-22       Impact factor: 3.169

5.  IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB Signaling.

Authors:  Yuan-Hua Xu; Zheng-Li Li; Sheng-Feng Qiu
Journal:  Transl Oncol       Date:  2018-01-04       Impact factor: 4.243

6.  Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer.

Authors:  Yuanyuan Gu; Shuoxin Liu; Xiaodan Zhang; Guimin Chen; Hongwei Liang; Mengchao Yu; Zhicong Liao; Yong Zhou; Chen-Yu Zhang; Tao Wang; Chen Wang; Junfeng Zhang; Xi Chen
Journal:  Protein Cell       Date:  2017-03-31       Impact factor: 14.870

7.  RNA-binding protein SORBS2 suppresses clear cell renal cell carcinoma metastasis by enhancing MTUS1 mRNA stability.

Authors:  Qi Lv; Fan Dong; Yong Zhou; Zhiping Cai; Gangmin Wang
Journal:  Cell Death Dis       Date:  2020-12-12       Impact factor: 8.469

8.  lncRNA LIFR‑AS1 inhibits gastric carcinoma cell proliferation, migration and invasion by sponging miR‑4698.

Authors:  Jiangqiao Zhao; Xiaoning Li; Liping Fu; Na Zhang; Jiaping Yang; Jianhui Cai
Journal:  Mol Med Rep       Date:  2020-12-23       Impact factor: 2.952

Review 9.  Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer.

Authors:  Maria M Haykal; Sylvie Rodrigues-Ferreira; Clara Nahmias
Journal:  Cells       Date:  2021-05-01       Impact factor: 6.600

10.  Gastric Cancer Heterogeneity and Clinical Outcomes.

Authors:  Rachel E Sexton; Mohammed Najeeb Al Hallak; Md Hafiz Uddin; Maria Diab; Asfar S Azmi
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.